Abstract
The current antidepressant drugs are ineffective in 30 to 40% of the treated patients; hence, the pathophysiology of the disease needs to be further elucidated. We used the chronic mild stress (CMS) paradigm to induce anhedonia, a core symptom of major depression, in rats. A fraction of the animals exposed to CMS is resistant to the development of anhedonia; they are CMS resilient. In the CMS-sensitive animals, the induced anhedonic state is reversed in 50% of the animals when treating with escitalopram, whereas the remaining animals are treatment resistant. We used the microarray and the real-time quantitative reverse transcription polymerase chain reaction technique, as well as the ingenuity pathway analysis software to identify the differential gene expression pathways, which are associated with the occurrence of the treatment resistance and the stress-resilient rats. In the hippocampus, we found a significant upregulation of apoptotic pathways in the treatment-resistant animals and significantly increased expression levels of genes involved in hippocampal signaling in the CMS-resilient rats. We hypothesize that sensitivity to the stress-induced anhedonia in rats is correlated with the impairment of hippocampal neurogenesis.
Similar content being viewed by others
Abbreviations
- APP:
-
amyloid beta precursor protein
- CMS:
-
chronic mild stress
- CMS-Es-R:
-
chronic mild stress sensitive escitalopram responders
- CMS-Es-NR:
-
chronic mild stress sensitive escitalopram non-responders
- CMS-RS:
-
chronic mild stress resilient
- CMS-V:
-
chronic mild stress sensitive vehicle
- IPA:
-
ingenuity pathway analysis
- qRT-PCR:
-
(real-time) quantitative reverse transcription-polymerase chain reaction
- RT-PCR:
-
reverse transcription-polymerase chain reaction
- TNF:
-
tumor necrosis factor
- U-Es:
-
unchallenged escitalopram
- U-V:
-
unchallenged vehicle
References
Adler, M. W., Geller, E. B., Chen, X., & Rogers, T. J. (2005). Viewing chemokines as a third major system of communication in the brain. AAPS Journal, 7, E865–E870..
Alonso, R., Griebel, G., Pavone, G., Stemmelin, J., Le, F. G., & Soubrie, P. (2004). Blockade of CRF(1) or V(1b) receptors reverses stress-induced suppression of neurogenesis in a mouse model of depression. Molecular Psychiatry, 9, 278–286, 224.
Bai, F., Bergeron, M., & Nelson, D. L. (2003). Chronic AMPA receptor potentiator (LY451646) treatment increases cell proliferation in adult rat hippocampus. Neuropharmacology, 44, 1013–1021.
Barlow, A., de, G. E., & Pachnis, V. (2003). Enteric nervous system progenitors are coordinately controlled by the G protein-coupled receptor EDNRB and the receptor tyrosine kinase RET. Neuron, 40, 905–916.
Berman, R. M., Narasimhan, M., & Charney, D. S. (1997). Treatment-refractory depression: definitions and characteristics. Depression and Anxiety, 5, 154–164.
Bisgaard, C. F., Jayatissa, M. N., Enghild, J. J., Sanchez, C., Artemychyn, R., & Wiborg, O. (2007). Proteomic investigation of the ventral rat hippocampus link DRP-2 to escitalopram treatment resistance and SNAP to stress resilience in the chronic mild stress rat model of depression. Journal of Molecular Neuroscience, 32, 132–144.
Bustin, S. A. (2000). Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays. Journal of Molecular Endocrinology, 25, 169–193.
Cacci, E., Claasen, J. H., & Kokaia, Z. (2005). Microglia-derived tumor necrosis factor-alpha exaggerates death of newborn hippocampal progenitor cells in vitro. Journal of Neuroscience Research, 80, 789–797.
Choi, J. S., Kim, S. Y., Park, H. J., Cha, J. H., Choi, Y. S., Kang, J. E., Chung, J. W., Chun, M. H., & Lee, M. Y. (2003). Upregulation of gp130 and differential activation of STAT and p42/44 MAPK in the rat hippocampus following kainic acid-induced seizures. Brain Research: Molecular Brain Research, 119, 10–18.
Dallas, P. B., Gottardo, N. G., Firth, M. J., Beesley, A. H., Hoffmann, K., Terry, P. A., Freitas, J. R., Boag, J. M., Cummings, A. J., & Kees, U. R. (2005). Gene expression levels assessed by oligonucleotide microarray analysis and quantitative real-time RT-PCR—how well do they correlate? BioMed Central Genomics, 6, 59.
Dore, S., Kar, S., & Quirion, R. (1997). Insulin-like growth factor I protects and rescues hippocampal neurons against beta-amyloid- and human amylin-induced toxicity. Proceedings of the National Academy of Sciences of the United States of America, 94, 4772–4777.
Fava, M. (2003). Diagnosis and definition of treatment-resistant depression. Biological Psychiatry, 53, 649–659.
Giunta, S., Valli, M. B., Galeazzi, R., Fattoretti, P., Corder, E. H., & Galeazzi, L. (2005). Transthyretin inhibition of amyloid beta aggregation and toxicity. Clinical Biochemistry, 38, 1112–1119.
Heine, V. M., Maslam, S., Zareno, J., Joels, M., & Lucassen, P. J. (2004). Suppressed proliferation and apoptotic changes in the rat dentate gyrus after acute and chronic stress are reversible. European Journal of Neurosciences, 19, 131–144.
Holderbach, R., Clark, K., Moreau, J. L., Bischofberger, J., & Normann, C. (2007). Enhanced long-term synaptic depression in an animal model of depression. Biological Psychiatry, 62, 92–100.
Jacobs, B. L. (2002). Adult brain neurogenesis and depression. Brain, Behavior and Immunity, 16, 602–609.
Jayatissa, M. N., Bisgaard, C., Tingstrom, A., Papp, M., & Wiborg, O. (2006). Hippocampal cytogenesis correlates to escitalopram-mediated recovery in a chronic mild stress rat model of depression. Neuropsychopharmacology, 31, 2395–2404.
Lee, K. J., Kim, S. J., Kim, S. W., Choi, S. H., Shin, Y. C., Park, S. H., Moon, B. H., Cho, E., Lee, M. S., Choi, S. H., Chun, B. G., & Shin, K. H. (2006). Chronic mild stress decreases survival, but not proliferation, of new-born cells in adult rat hippocampus. Experimental and Molecular Medecine, 38, 44–54.
Marcon, G., Giaccone, G., Canciani, B., Cajola, L., Rossi, G., De, G. L., Salmona, M., Bugiani, O., & Tagliavini, F. (1999). A betaPP peptide carboxyl-terminal to Abeta is neurotoxic. American Journal of Pathology, 154, 1001–1007.
Matsuo, N., Hoshino, M., Yoshizawa, M., & Nabeshima, Y. (2002). Characterization of STEF, a guanine nucleotide exchange factor for Rac1, required for neurite growth. Journal of Biological Chemistry, 277, 2860–2868.
McMurtry, M. S., Moudgil, R., Hashimoto, K., Bonnet, S., Michelakis, E. D., & Archer, S. L. (2007). Overexpression of human bone morphogenetic protein receptor II does not ameliorate monocrotaline pulmonary arterial hypertension. American Journal of Physiology: Lung Cellular and Molecular Physiology, 292, L872–L878.
Moreau, J. L., Jenck, F., Martin, J. R., Mortas, P., & Haefely, W. (1993). Effects of moclobemide, a new generation reversible Mao-A inhibitor, in a novel animal model of depression. Pharmacopsychiatry, 26, 30–33.
Moreau, J. L., Scherschlicht, R., Jenck, F., & Martin, J. R. (1995). Chronic mild stress-induced anhedonia model of depression; sleep abnormalities and curative effects of electroshock treatment. Behavioral Pharmacology, 6, 682–687.
Muscat, R., Papp, M., & Willner, P. (1992). Reversal of stress-induced anhedonia by the atypical antidepressants, fluoxetine and maprotiline. Psychopharmacology (Berl), 109, 433–438.
Page, R. D. (1996). Treeview: an application to display phylogenetic trees on personal computers. Computer Applications in the Biosciences, 12, 357–358.
Papp, M., Willner, P., & Muscat, R. (1991). An animal model of anhedonia: attenuation of sucrose consumption and place preference conditioning by chronic unpredictable mild stress. Psychopharmacology (Berl), 104, 255–259.
Porsolt, R. D., & Papp, M. (1998). Psychiatric models of disease: Depression. In S.J. Enna, M. Williams, J. W. Ferkany, T. Kenakin, P. Moser, & B. Ruggeri (Eds.) Current protocols in Pharmacology pp. 5.9.1–5.9.8. New York: Wiley.
Reus, V. I. (2006). Chapter 371: mental disorders. In D. L. Kasper, E. Braunwald, A. S. Fauci, S. L. Hauser, & D. L. Longo (Eds.) Harrison’s internal medicine (16st ed.). McGraw-Hill: New York.
Sanchez, C., Gruca, P., & Papp, M. (2003). R-citalopram counteracts the antidepressant-like effect of escitalopram in a rat chronic mild stress model. Behavioural Pharmacology, 14, 465–470.
Shin, M. K., Levorse, J. M., Ingram, R. S., & Tilghman, S. M. (1999). The temporal requirement for endothelin receptor-B signalling during neural crest development. Nature, 402, 496–501.
Smyth, G. K., & Speed, T. (2003). Normalization of cDNA microarray data. Methods, 31, 265–273.
Soti, C., Nagy, E., Giricz, Z., Vigh, L., Csermely, P., & Ferdinandy, P. (2005). Heat shock proteins as emerging therapeutic targets. British Journal of Pharmacology, 146, 769–780.
Strekalova, T., Gorenkova, N., Schunk, E., Dolgov, O., & Bartsch, D. (2006). Selective effects of citalopram in a mouse model of stress-induced anhedonia with a control for chronic stress. Behavioural Pharmacology, 17, 271–287.
Strekalova, T., Spanagel, R., Bartsch, D., Henn, F. A., & Gass, P. (2004). Stress-induced anhedonia in mice is associated with deficits in forced swimming and exploration. Neuropsychopharmacology, 29, 2007–2017.
Tanapat, P., Galea, L. A., & Gould, E. (1998). Stress inhibits the proliferation of granule cell precursors in the developing dentate gyrus. International Journal of Developmental Neuroscience, 16, 235–239.
Walker, A. M. (2005). Prolactin receptor antagonists. Current Opininion in Investigational Drugs, 6, 378–385.
Wang, Y., Barbacioru, C., Hyland, F., Xiao, W., Hunkapiller, K. L., Blake, J., Chan, F., Gonzalez, C., Zhang, L., & Samaha, R. R. (2006). Large scale real-time PCR validation on gene expression measurements from two commercial long-oligonucleotide microarrays. BioMed Central Genomics, 7, 59.
Willner, P. (1997). Validity, reliability and utility of the chronic mild stress model of depression: a 10-year review and evaluation. Psychopharmacology (Berl), 134, 319–329.
Willner, P. (2005). Chronic mild stress (CMS) revisited: consistency and behavioural-neurobiological concordance in the effects of CMS. Neuropsychobiology, 52, 90–110.
Willner, P., Towell, A., Sampson, D., Sophokleous, S., & Muscat, R. (1987). Reduction of sucrose preference by chronic unpredictable mild stress, and its restoration by a tricyclic antidepressant. Psychopharmacology (Berl), 93, 358–364.
Ye, G. L., Yi, S., Gamkrelidze, G., Pasternak, J. F., & Trommer, B. L. (2005). AMPA and NMDA receptor-mediated currents in developing dentate gyrus granule cells. Brain Research: Developmental Brain Research, 155, 26–32.
Yuen, T., Wurmbach, E., Pfeffer, R. L., Ebersole, B. J., & Sealfon, S. C. (2002). Accuracy and calibration of commercial oligonucleotide and custom cDNA microarrays. Nucleic Acids Research, 30, e48.
Ziv, Y., Ron, N., Butovsky, O., Landa, G., Sudai, E., Greenberg, N., Cohen, H., Kipnis, J., & Schwartz, M. (2006). Immune cells contribute to the maintenance of neurogenesis and spatial learning abilities in adulthood. Nature Neuroscience, 9, 268–275.
Acknowledgments
The authors would like to thank Ph.D. Arne Mørk at H. Lundbeck, Copenhagen for excellent advice on neuropsychopharmacology in general. We also thank Jan Torleif Pedersen and Karina Fog at H. Lundbeck, Copenhagen, for instructions on the use of the Ingenuity Pathway Analysis software. Specifically, we are grateful for the use of the Lundbeck license of IPA. Finally, we are grateful to Lundbeckfonden and the Danish Medical Research Council for supporting the project.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bergström, A., Jayatissa, M.N., Thykjær, T. et al. Molecular Pathways Associated with Stress Resilience and Drug Resistance in the Chronic Mild Stress Rat Model of Depression—a Gene Expression Study. J Mol Neurosci 33, 201–215 (2007). https://doi.org/10.1007/s12031-007-0065-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12031-007-0065-9